| Phase 2 | 2 | |
| Phase 2/3 | 1 | |
| Phase 3 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06932471 | Study of Safety and Efficacy of MY008211A in Patients With Residual Anemia Despite… | Paroxysmal Nocturnal Hemoglobinuria | Recruiting | 2025-05-09 |
| NCT06932744 | Study of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH)… | Paroxysmal Nocturnal Haemoglobinuria (PNH) | Recruiting | 2025-05-09 |
| NCT06716970 | QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension | Essential Hypertension | Not Yet Recruiting | 2024-12-06 |
| Phase 2/3 | ||||
| NCT06933914 | Long-term Safety and Tolerability of MY008211A Tablets in Patients With Paroxysmal… | Paroxysmal Nocturnal Hemoglobinuria (PNH) | Recruiting | 2025-04-18 |
| Phase 2 | ||||
| NCT06134414 | Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal… | Paroxysmal Nocturnal Hemoglobinuria (PNH) | Not Yet Recruiting | 2025-07-29 |
| NCT06687174 | Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary… | IgA Nephropathy (IgAN) | Not Yet Recruiting | 2024-11-18 |
Hypertension (1)